Relief Therapeutics Holding AG

RLFTD · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17-$98-$51-$35
Dep. & Amort.$3$3$4$2
Deferred Tax-$2-$14-$4-$1
Stock-Based Comp.$0$1$2$1
Change in WC$3-$1$6-$5
Other Non-Cash$11$91$19$2
Operating Cash Flow-$3-$18-$24-$36
Investing Activities
PP&E Inv.-$0-$0-$1-$14
Net Acquisitions$0$0-$8-$17
Inv. Purchases$0-$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4$9$0-$14
Investing Cash Flow$4$9-$8-$30
Financing Activities
Debt Repay.-$0-$1-$0-$6
Stock Issued$0$5$7$76
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$0-$0-$3
Financing Cash Flow-$1$4$6$68
Forex Effect-$0$0$0-$0
Net Chg. in Cash$1-$5-$26$2
Supplemental Information
Beg. Cash$15$19$45$43
End Cash$15$15$19$45
Free Cash Flow-$3-$18-$25-$49
Relief Therapeutics Holding AG (RLFTD) Financial Statements & Key Stats | AlphaPilot